Making babies: HDBuzz's feature article on fertility technologies that can help at-risk people to have HD-free childr
Positive results from tests of a new 'KMO inhibiting' drug in Huntington's disease mice
Intermediate alleles and reduced penetrance – the genetic 'gray area' of Huntington’s disease, explained
Dimebon fails to improve symptoms in HD patients in the HORIZON trial
Is gene silencing as exciting as it sounds for HD, and what might the future hold?
HDBuzz interviews Graeme Bilbe, Global Head for Neuroscience at pharmaceutical giant Novartis, about their HD researc
HDBuzz interviews three top scientists from CHDI, the biggest funder and driver of HD research worldwide
Day 3 of CHDI’s HD therapeutics conference: growth factors and CHDI’s advanced therapies
Day 2 of CHDI’s HD therapeutics conference: figuring out energy problems in HD